Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Alopecia areata involves immune response and gene changes affecting hair loss.

A gene mutation in mice causes permanent hair loss and skin issues.

Minoxidil helps hair regrowth in alopecia, but more research needed.

Children with HIV often have skin problems that can indicate the severity of their immune system damage.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

Alopecia in patients with epidermolysis bullosa varies in severity and is often caused by skin blistering or trauma.

Differences in growth factors in platelet-rich plasma therapy for hair loss can vary between patients and can be influenced by the devices used, possibly leading to inconsistent results.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Lgr5 is a marker for active, long-lasting stem cells in mouse hair follicles.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

Stem cell offspring help control their parent stem cells, affecting tissue health, healing, and cancer.

The skin is a complex barrier for drug penetration, but understanding its structure and interactions can improve drug delivery methods.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Vitiligo affects overall health and self-esteem, needing more research and awareness.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Lowest effective minoxidil concentration is 1%, but 2% works better for male pattern baldness.